eBioMedicine Profile Banner
eBioMedicine – The Lancet Discovery Science Profile
eBioMedicine – The Lancet Discovery Science

@eBioMedicine

Followers
10K
Following
1K
Media
2K
Statuses
4K

Leading biomedical #openaccess journal, bridging the gap between basic and clinical research. Part of @TheLancet Discovery Science. IF=9.7 #Lancet200

Cambridge MA-USA and London UK
Joined June 2014
Don't wanna be here? Send us removal request.
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
6 months
eBioMedicine is leaving this platform but joining others ⤵️ . You can now find us on.Bluesky 👉 @ebiomedicine.bsky.social.LinkedIn 👉 🌐 And, of course, online at Follow us!.
0
0
1
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
8 months
RT @HPRURespiratory: Why do some people avoid COVID-19 infection despite high levels of exposure? We discovered an ultra-early, interferon-….
Tweet card summary image
thelancet.com
Our interferon-associated signature of early SARS-CoV-2 infection characterises a subgroup of exposed, uninfected contacts in three independent cohorts who may have successfully aborted infection...
0
2
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
8 months
Using disease information from routine clinical radiology reports enables accurate anomaly detection without requiring manual annotations @synapse_r @IVR57958121 Read #openaccess now 👇
Tweet card summary image
thelancet.com
Using disease information from routine clinical free-text radiology reports allows development of accurate anomaly detection models without requiring manual annotations. This approach is applicable...
0
0
2
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
10 months
RT @ljiresearch: New #COVID19 study shows how a novel mouse model can fuel pandemic preparedness @eBioMedicine #Vi….
Tweet card summary image
lji.org
LJI and Synbal, Inc. scientists develop new tool for pandemic preparedness
0
1
0
@grok
Grok
9 hours
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
43
24
257
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
10 months
RT @iliciub1: 💉Grateful for the opportunity to discuss our work published in July in Lancet’s @eBioMedicine on this podcast, alongside @heq….
Tweet card summary image
podfollow.com
The World Health Organisation has recommended two licenced malaria vaccines. Those vaccines have been a long time coming - but are they the best? In this extended episode of the Johns Hopkins Malar...
0
5
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
10 months
RT @ljiresearch: New from @eBioMedicine - LJI researchers investigate #COVID19 immune responses with new mouse models: . "Influence of Th1….
0
2
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
10 months
RT @TheLancet: Biomarkers of neurodegeneration: the global challenges and benefits are are explored in a new @LancetLongevity@eBioMedicine….
0
9
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
10 months
RT @LancetLongevity: The @eBioMedicine and @LancetLongevity Series BioMarkers of Neurogeneration: Introduction by S….
0
6
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
10 months
RT @UniLeipzig: Researchers at #UniLeipzig and @ChariteBerlin have developed an approach using #AI to compare the molecular mechanisms of #….
0
3
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
11 months
RT @CSPRG_Imperial: Post-Doc Appreciation Week =@rharewood's work in @eBioMedicine. The largest study of its kind links dysregulated lipid….
0
1
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
11 months
Researchers @UCLeye have revealed tissue-specific somatic instability underlies a common age-related cause of visual loss. Translationally relevant findings for repeat-expansion mediated diseases #OpticalGenomeMapping #RepeatExpansions.Read #openaccess👇.
Tweet card summary image
thelancet.com
OGM is a powerful tool for analysing somatic instability of repeat loci and reveals here the extreme levels of CTG18.1 instability occurring within diseased CECs underpinning FECD pathophysiology,...
0
5
17
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
11 months
🔊 Prof. Torben Hansen from the Novo Nordisk Foundation Centre for Basic Metabolic Research, @UCPH_Research, speaks to Dr Gita Thapaliya about the interplay between birth weight and obesity in determining childhood and adolescent cardiometabolic risks 👇.
0
1
3
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
11 months
RT @MasoudTahmasian: Struggling with poor #sleep😴& #anxiety🎃? .Our study in @eBioMedicine applied #MachineLearning to explore their complex….
0
8
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
11 months
RT @DermalCell: In a recent @eBioMedicine release, Dr. Esther Lim & collaborators provide a framework to study treatment response within di….
0
1
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
11 months
RT @TomVanAgtmael: Paper Alert!.Our new work shows collagen IV variants act by collagen IV deficiency, hypertrophic remodeling and endothel….
Tweet card summary image
thelancet.com
COL4A1/COL4A2 variants act in genetic and sporadic CSVD with ICH via dysregulated EDH, and altered vascular wall thickness and biomechanics due to lower collagen IV levels and/or mutant collagen IV...
0
15
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
1 year
RT @Fr_Lebreton: Our new paper with Tom Russo’s lab is out in @eBioMedicine We took out individual genes, combinations, or the whole virule….
0
10
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
1 year
Read the review #openaccess now 👇.
Tweet card summary image
thelancet.com
Pancreatic ductal adenocarcinoma (PDAC) represents the most prevalent type of pancreatic cancer and ranks among the most aggressive tumours, with a 5-year survival rate of less than 11%. Projections...
@nuriavazquezbe
Núria Vázquez-Bellón 👩‍🔬
1 year
I'm very excited to share our latest publication in @EBioMedicine @TheLancet! This review delves into the crucial role of #TAMReceptors—Tyro3, AXL & MerTK—in PDAC #PancreaticCancer, one of the deadliest cancers. #CancerResearch @PNavarro_Lab 🧵👇.
Tweet media one
0
2
5
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
1 year
RT @dngman: To preprocess or not to preprocess your #EEG 🔮when using #ML? 💫An enhanced version of our latest work at @Roche is now publishe….
0
39
0
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
1 year
Congratulations to our authors and peer reviewers, whose expertise and hard work enable us to continue publishing some of the best science for better lives. This is as much your achievement!
0
0
1
@eBioMedicine
eBioMedicine – The Lancet Discovery Science
1 year
We are an internationally trusted source for translational biomedical research. While a partial measurement of our impact, we are pleased to share our Impact Factor of 9·7 and CiteScore of 17·7.
1
0
3